Cargando…
Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia
Ataxia telangiectasia (A-T) is a primary immunodeficiency with mutations in the gene encoding the A-T mutated (ATM) protein that interacts with immune, hematopoietic, and endocrine targets resulting in broad multi-systemic clinical manifestations with a devastating outcome. Apart from a progressive...
Autores principales: | Bakhtiar, Shahrzad, Woelke, Sandra, Huenecke, Sabine, Kieslich, Matthias, Taylor, Alexander Malcolm, Schubert, Ralf, Zielen, Stefan, Bader, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215822/ https://www.ncbi.nlm.nih.gov/pubmed/30420857 http://dx.doi.org/10.3389/fimmu.2018.02495 |
Ejemplares similares
-
Treatment of Granulomas in Patients With Ataxia Telangiectasia
por: Woelke, Sandra, et al.
Publicado: (2018) -
Hematopoietic Stem Cell Transplantation Restores Naïve T-Cell Populations in Atm-Deficient Mice and in Preemptively Treated Patients With Ataxia-Telangiectasia
por: Duecker, Ruth, et al.
Publicado: (2019) -
Diabetes in Patients With Ataxia Telangiectasia: A National Cohort Study
por: Donath, Helena, et al.
Publicado: (2020) -
Progressive Liver Disease in Patients With Ataxia Telangiectasia
por: Donath, Helena, et al.
Publicado: (2019) -
Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia
por: Woelke, S., et al.
Publicado: (2020)